Alzheimer’s drug now comes as a home injection
Leqembi Iqlik lets patients self-administer anti-amyloid drug in about 15 seconds, cutting out the IV chair treatment used to require. For the past two years, staying on Leqembi has meant a recurring appointment nobody looks forward to: an IV chair, a drip line and an hour or more of watching a bag
<p>Leqembi Iqlik lets patients self-administer anti-amyloid drug in about 15 seconds, cutting out the IV chair treatment used to require. For the past two years, staying on Leqembi has meant a recurring appointment nobody looks forward to: an IV chair, a drip line and an hour or more of watching a bag </p>